Joel A Sincavage

Array ( [id] => 6506141 [patent_doc_number] => 20100210514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'RNAi Inhibition of Alpha-ENaC Expression' [patent_app_type] => utility [patent_app_number] => 12/771614 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38431 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210514.pdf [firstpage_image] =>[orig_patent_app_number] => 12771614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241022 [patent_doc_number] => 20120149757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING' [patent_app_type] => utility [patent_app_number] => 13/264353 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14566 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757162 [patent_doc_number] => 20120029056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'DIFFERENTIALLY EXPRESSED MICRORNAS AS BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF SJÖGREN\'S SYNDROME' [patent_app_type] => utility [patent_app_number] => 13/262125 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38374 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029056.pdf [firstpage_image] =>[orig_patent_app_number] => 13262125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009383 [patent_doc_number] => 08524681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof' [patent_app_type] => utility [patent_app_number] => 12/727336 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 77 [patent_no_of_words] => 35455 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12727336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8200991 [patent_doc_number] => 08188061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'RNAi modulation of APOB and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/728139 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 41265 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188061.pdf [firstpage_image] =>[orig_patent_app_number] => 12728139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720821 [patent_doc_number] => 20120010156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'TREATMENT OF DELTA-LIKE 1 HOMOLOG (DLK1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO DLK1' [patent_app_type] => utility [patent_app_number] => 13/256710 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26847 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010156.pdf [firstpage_image] =>[orig_patent_app_number] => 13256710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6566611 [patent_doc_number] => 20100234281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'ANTIBACTERIAL ANTISENSE OLIGONUCLEOTIDE AND METHOD' [patent_app_type] => utility [patent_app_number] => 12/723413 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 38539 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234281.pdf [firstpage_image] =>[orig_patent_app_number] => 12723413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6566574 [patent_doc_number] => 20100234280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/723035 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18262 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234280.pdf [firstpage_image] =>[orig_patent_app_number] => 12723035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545154 [patent_doc_number] => 20100222231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'USE OF ANTISENSE OLIGONUCLEOTIDE LIBRARIES FOR IDENTIFYING GENE FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/716900 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29559 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222231.pdf [firstpage_image] =>[orig_patent_app_number] => 12716900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875829 [patent_doc_number] => 08470795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Antisense modulation of kinesin-like 1 expression' [patent_app_type] => utility [patent_app_number] => 12/714361 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26762 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12714361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6230292 [patent_doc_number] => 20100184207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHODS FOR PRODUCING INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC USES FOR SUCH MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/709925 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7661 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184207.pdf [firstpage_image] =>[orig_patent_app_number] => 12709925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6459792 [patent_doc_number] => 20100190195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Use of Hepatitis B X-Interacting Protein (HBXIP) in Modulation of Apoptosis' [patent_app_type] => utility [patent_app_number] => 12/698918 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22878 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190195.pdf [firstpage_image] =>[orig_patent_app_number] => 12698918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627643 [patent_doc_number] => 20100172966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Methods and compositions for cellular reprogramming' [patent_app_type] => utility [patent_app_number] => 12/658042 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22606 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172966.pdf [firstpage_image] =>[orig_patent_app_number] => 12658042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561741 [patent_doc_number] => 20110275574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'METHOD OF INHIBITING PROLIFERATION OF HEPATIC STELLATE CELLS' [patent_app_type] => utility [patent_app_number] => 13/144526 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11903 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275574.pdf [firstpage_image] =>[orig_patent_app_number] => 13144526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195506 [patent_doc_number] => 20110027260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/646747 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21772 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027260.pdf [firstpage_image] =>[orig_patent_app_number] => 12646747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9345040 [patent_doc_number] => 08664188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'siRNA compositions and methods for potently inhibiting viral infection' [patent_app_type] => utility [patent_app_number] => 12/636234 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 43 [patent_no_of_words] => 19502 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12636234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518478 [patent_doc_number] => 20100203013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Treating Hepatitis C Virus Infection' [patent_app_type] => utility [patent_app_number] => 12/631917 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3221 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203013.pdf [firstpage_image] =>[orig_patent_app_number] => 12631917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267744 [patent_doc_number] => 20100298408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Oligonucleotide Compositions with Enhanced Efficiency' [patent_app_type] => utility [patent_app_number] => 12/630523 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23310 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298408.pdf [firstpage_image] =>[orig_patent_app_number] => 12630523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328678 [patent_doc_number] => 08236775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Compositions and methods for siRNA inhibition of HIF-1 α' [patent_app_type] => utility [patent_app_number] => 12/630077 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9788 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12630077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202984 [patent_doc_number] => 20110065770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 12/592668 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10808 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065770.pdf [firstpage_image] =>[orig_patent_app_number] => 12592668 [rel_patent_id] =>[rel_patent_doc_number] =>)